Filing Flows › AdaptHealth (AHCO) › Q2 2026
AdaptHealth (AHCO) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 4, 2026
AdaptHealth (AHCO) reported revenue of $740M for the second quarter 2026 (Q2 2026), +13% from a year earlier and -10% from the quarter before. Operating margin was -18.6%, net loss $133M (17.9% of revenue).
AdaptHealth, Q2 2026: revenue $740M (+13% year over year), operating margin -18.6%, net loss $133M, operating cash flow $145M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $740M | -10% | +13% |
| Operating profit | −$138M | -2611% | -274% |
| Net earnings | −$133M | — | -1004% |
| Operating cash flow | $145M | +55% | -10% |
What changed
Revenue was $740.3M in Q2 2026, up 13% year over year and down 10% from the previous quarter. Sleep Health was the largest line at 52% of revenue. Sleep Health added $51.8M year over year (up 15%), 62% of the total change.
Operating costs exceeded revenue by $137.8M, an operating margin of -18.6%. Total costs grew 48% against revenue growth of 13%. The quarter ended with a net loss of $132.7M, wider than the previous quarter's $14.9M loss.
Operating cash flow was $145.3M (down 10% year over year). Non-cash charges added back $120.3M of depreciation and amortization and $5.6M of share-based compensation. Working capital and other items added $152.2M. Capital expenditures of $166.2M exceeded it, leaving free cash flow of −$20.9M.
Questions
What was AdaptHealth's revenue in the second quarter 2026?
AdaptHealth (AHCO) reported revenue of $740M for the second quarter 2026 (Q2 2026), +13% from a year earlier and -10% from the quarter before.
Was AdaptHealth profitable in the second quarter 2026?
Operating loss was $138M (-18.6% of revenue) and net loss $133M.
Source: AdaptHealth 10-Q on SEC EDGAR.